docetaxel anhydrous has been researched along with diethylstilbestrol in 3 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (diethylstilbestrol) | Trials (diethylstilbestrol) | Recent Studies (post-2010) (diethylstilbestrol) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 8,585 | 322 | 491 |
| Protein | Taxonomy | docetaxel anhydrous (IC50) | diethylstilbestrol (IC50) |
|---|---|---|---|
| high affinity choline transporter 1 isoform a | Homo sapiens (human) | 12.5893 | |
| Estrogen receptor | Homo sapiens (human) | 0.1312 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 3.67 | |
| Adenosine receptor A3 | Homo sapiens (human) | 2.208 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.963 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 2.208 | |
| Substance-K receptor | Homo sapiens (human) | 9.553 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 7.763 | |
| Prostaglandin G/H synthase 1 | Homo sapiens (human) | 5.6 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 3.67 | |
| Thromboxane-A synthase | Homo sapiens (human) | 4.359 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 4.79 | |
| Adenosine receptor A2a | Homo sapiens (human) | 9.013 | |
| Adenosine receptor A1 | Homo sapiens (human) | 2.856 | |
| Mu-type opioid receptor | Homo sapiens (human) | 5.778 | |
| D(3) dopamine receptor | Homo sapiens (human) | 8.796 | |
| Delta-type opioid receptor | Homo sapiens (human) | 2.718 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 4.563 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 3.14 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 2.208 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 1.071 | |
| Aldehyde oxidase | Homo sapiens (human) | 0.46 | |
| Estrogen receptor beta | Homo sapiens (human) | 0.1588 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 0.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujinami, K; Miura, T; Osada, Y; Takizawa, A | 1 |
| Bossi, A; De La Motte Rouge, T; Escudier, B; Fizazi, K; Gross-Goupil, M; Loriot, Y; Massard, C; Serrate, C | 1 |
| Attard, G; Bianchini, D; de Bono, JS; Dearnaley, D; Ferraldeschi, R; Lorente, D; Mukherji, D; Omlin, A; Parker, C; Pezaro, CJ; Sandhu, S; Van As, N; Zaidi, S | 1 |
3 other study(ies) available for docetaxel anhydrous and diethylstilbestrol
| Article | Year |
|---|---|
[Combination chemotherapy with docetaxel and cisplatin in patients with hormone-refractory prostate cancer].
Topics: Aged; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Diethylstilbestrol; Docetaxel; Drug Administration Schedule; Drug Resistance, Neoplasm; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Taxoids | 2005 |
Diethylstilbestrol (DES) retains activity and is a reasonable option in patients previously treated with docetaxel for castration-resistant prostate cancer.
Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Diethylstilbestrol; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Salvage Therapy; Taxoids; Time Factors; Treatment Outcome | 2009 |
Antitumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer.
Topics: Adult; Aged; Aged, 80 and over; Androgen Antagonists; Androstenes; Androstenols; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Diethylstilbestrol; Disease Progression; Docetaxel; Estrogens, Non-Steroidal; Humans; Male; Middle Aged; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Steroid 17-alpha-Hydroxylase; Taxoids; Treatment Outcome | 2013 |